GER2 Antibody is a polyclonal antibody raised in rabbits against recombinant Arabidopsis thaliana GER2 protein. It specifically recognizes GER2 protein (UniProt accession number Q9LMU0) from Arabidopsis thaliana, making it a valuable tool for plant molecular biology research . This antibody is non-conjugated and provided in liquid form, stabilized in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . The antibody has been validated for use in enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications to ensure accurate identification of its target antigen.
GER2 Antibody should not be confused with HER2 (Human Epidermal growth factor Receptor 2) antibodies, which are widely used in cancer research and treatment. While HER2 antibodies target a tyrosine kinase receptor overexpressed in certain human cancer types (particularly breast cancer) , GER2 Antibody targets a plant-specific protein in Arabidopsis thaliana . This distinction is crucial for researchers to avoid experimental design errors and misinterpretation of literature. HER2 antibodies function in mammalian systems and are often used in oncology research, whereas GER2 Antibody is specifically designed for plant biology applications.
Based on available technical information, GER2 Antibody has been validated for two primary applications:
Western Blotting (WB): For detecting denatured GER2 protein from Arabidopsis thaliana samples, allowing researchers to determine protein expression levels and molecular weight .
Enzyme-Linked Immunosorbent Assay (ELISA): For quantitative detection of GER2 protein in solution-based assays .
These validated applications have been specifically tested to ensure the antibody's capacity to identify its target antigen reliably. Researchers should conduct preliminary validation experiments when adapting this antibody to other applications not explicitly specified in the technical documentation.
For optimal stability and performance of the GER2 Antibody, researchers should adhere to the following storage conditions:
Long-term storage: Store the antibody at either -20°C or -80°C immediately upon receipt .
Avoid freeze-thaw cycles: Repeated freezing and thawing can significantly reduce antibody activity through protein denaturation and aggregation .
Working aliquots: To prevent the need for repeated freeze-thaw cycles, prepare small working aliquots before freezing.
Storage buffer: The antibody is supplied in a stabilizing buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 . This formulation helps maintain stability during freeze-thaw transitions.
Thawing procedure: Thaw frozen antibody aliquots on ice or at 4°C rather than at room temperature to minimize potential degradation.
Adherence to these storage practices will help ensure consistent performance across experiments and maximize the useful lifetime of the antibody.
For optimal Western blotting results with GER2 Antibody, researchers should consider the following protocol recommendations:
Sample preparation:
Extract total protein from Arabidopsis thaliana tissues using appropriate lysis buffers
Quantify protein concentration using Bradford or BCA assay
Prepare samples in reducing loading buffer (containing DTT or β-mercaptoethanol)
Heat samples at 95°C for 5 minutes to denature proteins
Gel electrophoresis:
Use 10-12% SDS-PAGE gels for optimal separation
Load 20-50 μg of total protein per lane
Include molecular weight markers
Transfer:
Transfer proteins to PVDF or nitrocellulose membrane
Verify transfer efficiency with reversible staining (Ponceau S)
Blocking:
Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature
Primary antibody incubation:
Dilute GER2 Antibody (recommended starting dilution 1:500 to 1:2000)
Incubate overnight at 4°C with gentle agitation
Secondary antibody:
Use anti-rabbit HRP-conjugated secondary antibody
Incubate for 1 hour at room temperature
Detection:
Develop using enhanced chemiluminescence (ECL) substrate
Expose to X-ray film or capture using digital imaging system
Controls:
Include positive control (Arabidopsis thaliana wild-type extract)
Include negative control (extract from GER2 knockout lines if available)
This protocol should be optimized for specific experimental conditions and sample types.
When encountering non-specific binding issues with GER2 Antibody, researchers should implement the following troubleshooting strategies:
Optimize antibody concentration: Titrate the antibody to determine the minimum concentration needed for specific detection. High antibody concentrations often increase background and non-specific binding.
Modify blocking conditions:
Try alternative blocking agents (BSA, casein, commercial blocking buffers)
Increase blocking time from 1 hour to 2 hours
Consider adding 0.1-0.5% Tween-20 to blocking buffer
Increase washing stringency:
Increase number of wash steps (5-6 washes instead of 3)
Extend wash duration to 10 minutes per wash
Use higher concentration of detergent in wash buffer (0.1-0.2% Tween-20)
Pre-absorb the antibody:
Incubate diluted antibody with membrane containing non-target proteins (e.g., from knockout lines)
Remove antibodies bound to non-specific proteins by centrifugation
Modify sample preparation:
Ensure complete protein denaturation for Western blots
Consider using fresher samples to minimize degradation products
Adjust detection sensitivity:
Reduce exposure time during imaging
Dilute ECL substrate for Western blots
Include competitive controls:
Pre-incubate antibody with recombinant GER2 protein to confirm specificity
These approaches should be tested systematically, changing one variable at a time to identify the most effective solution for your specific experimental system.
GER2 Antibody can be leveraged for comprehensive studies of GER2 protein expression patterns across tissues and developmental stages through the following methodological approaches:
Tissue-specific Western blot analysis:
Harvest separate tissues (roots, leaves, stems, flowers, siliques)
Extract proteins using standardized protocols
Perform quantitative Western blots with GER2 Antibody
Normalize against housekeeping proteins (actin, tubulin)
Compare relative expression levels across tissues
Developmental time-course analysis:
Collect samples at defined developmental stages (seedling, vegetative, flowering)
Process samples simultaneously to minimize technical variation
Quantify GER2 protein levels by Western blot or ELISA
Plot expression changes over time
Cellular localization studies:
Use GER2 Antibody for immunohistochemistry or immunofluorescence
Prepare thin tissue sections or partially permeabilized cells
Determine subcellular localization
Co-stain with organelle markers to confirm localization patterns
Stress response profiling:
Subject plants to various abiotic/biotic stresses
Monitor GER2 protein expression changes in response to stress
Correlate protein levels with physiological responses
Quantitative analysis framework:
Employ densitometry software for Western blot quantification
Use biological and technical replicates (n≥3)
Perform appropriate statistical analyses (ANOVA with post-hoc tests)
Present data with error bars and significance indicators
This comprehensive approach allows researchers to create a detailed atlas of GER2 protein expression, providing insights into its biological functions across different tissues and developmental contexts.
While GER2 Antibody has not been explicitly validated for immunoprecipitation (IP), researchers interested in adapting it for this application should consider the following technical aspects:
Preliminary validation experiments:
Test antibody binding to native (non-denatured) GER2 protein
Perform dot blot or native PAGE Western blot to confirm recognition of folded protein
Determine optimal antibody-to-protein ratio through titration experiments
Immunoprecipitation protocol optimization:
Try different lysis buffers (varying detergent types and concentrations)
Test multiple binding conditions (temperature, incubation time)
Compare protein A, protein G, and mixed A/G beads for optimal capture
Evaluate pre-clearing strategies to reduce non-specific binding
Controls to include:
Input sample (before IP) to assess efficiency
IgG control from same species (rabbit) to identify non-specific binding
Lysate from GER2 knockout or knockdown plants as negative control
Reciprocal IP with known interacting proteins to confirm complex formation
Detection methods:
Western blot of IP products using GER2 Antibody or antibodies against potential interacting partners
Mass spectrometry analysis for unbiased identification of co-precipitated proteins
Crosslinking considerations:
Evaluate if chemical crosslinking (formaldehyde, DSP, BS3) improves capture of transient interactions
Optimize crosslinking conditions if implemented
Data analysis framework:
Quantify IP efficiency (% of input recovered)
Compare signal-to-noise ratio across different conditions
Apply statistical analysis to replicate experiments
These methodological considerations should guide the adaptation of GER2 Antibody for immunoprecipitation studies, enabling the investigation of protein-protein interactions involving GER2 in Arabidopsis thaliana.
When extending GER2 Antibody usage to other plant species, researchers should implement a systematic cross-reactivity assessment strategy:
Bioinformatic analysis:
Identify potential homologs through sequence alignment databases
Calculate sequence similarity percentages in the immunogenic region
Predict epitope conservation using structural modeling tools
Create a table of potential cross-reactive proteins based on sequence homology:
| Species | Protein Identifier | Sequence Similarity (%) | Predicted Cross-Reactivity |
|---|---|---|---|
| A. thaliana | Q9LMU0 (GER2) | 100% | High (target) |
| Close relative 1 | [ID] | [%] | [Prediction] |
| Close relative 2 | [ID] | [%] | [Prediction] |
| Distant relative | [ID] | [%] | [Prediction] |
Experimental validation:
Perform Western blot analysis on protein extracts from multiple plant species
Include positive control (A. thaliana) alongside test species
Look for bands at the predicted molecular weights of homologs
Confirm identity of cross-reactive bands by mass spectrometry
Specificity testing:
Pre-absorb antibody with recombinant GER2 protein
Test if pre-absorption eliminates all signals (target and cross-reactive)
Use knockout/knockdown lines where available to confirm specificity
Affinity determination:
Compare signal intensities between species using equivalent protein amounts
Perform antibody dilution series to estimate relative affinities
Calculate detection limits for each species
Documentation and reporting:
Document all cross-reactivity observations systematically
Report both positive and negative findings
Share results with antibody manufacturer and research community
This methodical approach allows researchers to define the taxonomic range in which the GER2 Antibody can be reliably used, expanding its research applications while maintaining experimental rigor.
When encountering unexpected bands in Western blots using GER2 Antibody, researchers should employ the following systematic analytical approach:
Characterize the unexpected bands:
Document precise molecular weights of all observed bands
Note band intensity patterns relative to the expected GER2 band
Determine if unexpected bands appear consistently across replicates
Potential biological explanations:
Post-translational modifications: Phosphorylation, glycosylation, or ubiquitination can increase molecular weight
Alternative splicing: Variant transcripts may produce proteins of different sizes
Proteolytic processing: Partial degradation or regulated cleavage may generate fragments
Protein complexes: Incomplete denaturation can result in higher molecular weight bands
Technical considerations:
Sample preparation issues: Insufficient denaturation or reduction
Gel artifacts: Uneven polymerization or air bubbles affecting migration
Transfer problems: Incomplete or uneven transfer to membrane
Non-specific binding: Cross-reactivity with related proteins
Validation experiments:
Repeat with varied denaturation conditions (stronger reducing agents, higher temperatures)
Include protease inhibitors in extraction buffer to prevent degradation
Test samples from GER2 knockout/knockdown plants to identify specific bands
Perform peptide competition assay to distinguish specific from non-specific signals
Consider mass spectrometry identification of proteins in unexpected bands
Analysis framework:
Create a table documenting all observed bands and their characteristics:
| Band MW (kDa) | Expected for GER2? | Consistency | Potential Identity | Validation Strategy |
|---|---|---|---|---|
| [MW] | Yes/No | Always/Sometimes | [Hypothesis] | [Approach] |
This structured approach transforms unexpected results into research opportunities, potentially revealing novel insights about GER2 protein biology, including possible isoforms, modifications, or interaction partners.
For accurate quantitative analysis of GER2 protein levels using GER2 Antibody, researchers should implement the following best practices:
Experimental design considerations:
Include biological replicates (n≥3) for statistical validity
Incorporate technical replicates to assess method variability
Design experiments with appropriate controls for normalization
Consider time-course sampling to capture dynamic changes
Sample preparation standardization:
Extract proteins using consistent protocols across all samples
Quantify total protein accurately using reliable methods (BCA or Bradford)
Load equal amounts of total protein in each lane/well
Prepare all samples simultaneously to minimize batch effects
Western blot quantification methods:
Use a wide dynamic range imaging system (digital preferred over film)
Ensure signals are within linear detection range (avoid saturation)
Perform densitometry using appropriate software (ImageJ, ImageLab)
Normalize target protein to validated housekeeping proteins (actin, GAPDH, tubulin)
Consider using total protein normalization methods (Stain-Free, Ponceau S)
ELISA quantification approaches:
Generate standard curves using recombinant GER2 protein
Ensure samples fall within the linear range of the standard curve
Run samples in duplicate or triplicate to assess technical variation
Calculate concentrations using a four-parameter logistic regression model
Statistical analysis framework:
Apply appropriate statistical tests based on experimental design:
t-test for two-group comparisons
ANOVA for multi-group comparisons
Repeated measures analysis for time-course data
Assess normality and homogeneity of variance
Report results with appropriate measures of central tendency and dispersion
Include p-values and indicate significance levels
Data presentation standards:
Present normalized data with error bars (SEM or SD)
Include representative blot images alongside quantitative graphs
Label all axes clearly with units of measurement
Indicate sample sizes and statistical significance
Adherence to these practices ensures that quantitative analyses of GER2 protein are reproducible, reliable, and statistically sound, facilitating meaningful biological interpretations.
GER2 Antibody should be evaluated in context with other methodologies for studying GER2 protein in Arabidopsis thaliana:
| Method | Advantages | Limitations | Complementarity with GER2 Antibody |
|---|---|---|---|
| GER2 Antibody (Immunodetection) | - Direct protein detection - Quantifiable - Reveals post-translational modifications - Applicable to various tissues | - Dependent on antibody specificity - May not distinguish closely related proteins - Limited spatial resolution | - Primary method for protein-level analysis |
| RT-qPCR (mRNA analysis) | - High sensitivity - Easy quantification - Isoform-specific detection | - No protein-level information - mRNA levels may not correlate with protein - No post-translational insights | - Complements antibody by providing transcript data - Can validate protein changes at mRNA level |
| GFP fusion proteins | - Live cell visualization - Subcellular localization - Dynamic studies possible | - Potential artifacts from fusion - Expression often not at native levels - Requires genetic transformation | - Antibody can validate GFP fusion results - Can verify if fusion affects protein stability |
| Mass spectrometry | - Unbiased detection - Can identify modifications - High specificity | - Complex sample preparation - Lower throughput - Limited quantification | - Antibody can verify MS identifications - MS can confirm antibody specificity |
| CRISPR/RNAi approaches | - Functional insights through loss-of-function - Tissue-specific manipulation | - Indirect assessment of function - Potential off-target effects | - Antibody confirms knockout efficiency - Validates phenotype correlation with protein loss |
This comparative analysis demonstrates that GER2 Antibody provides unique advantages for direct protein detection, while complementary approaches offer additional dimensions of understanding. A multi-method strategy combining GER2 Antibody with other techniques provides the most comprehensive characterization of GER2 protein biology in research settings.
Researchers can implement several sophisticated experimental approaches incorporating GER2 Antibody to elucidate protein-protein interactions:
Co-immunoprecipitation coupled with mass spectrometry:
Use GER2 Antibody to pull down GER2 protein complexes
Analyze co-precipitated proteins by LC-MS/MS
Employ quantitative proteomics (SILAC, TMT) to identify significant interactors
Compare interactomes under different conditions (developmental stages, stress)
Validate key interactions with reciprocal co-IP experiments
Proximity-dependent labeling approaches:
Generate fusion proteins linking GER2 to BioID or APEX enzymes
Use these enzymes to biotinylate proteins in close proximity to GER2
Capture biotinylated proteins with streptavidin
Confirm expression and functionality of fusion protein using GER2 Antibody
Identify interaction partners through mass spectrometry
In situ proximity ligation assay (PLA):
Use GER2 Antibody with antibodies against candidate interacting proteins
Apply species-specific secondary antibodies with attached oligonucleotides
Proximity of proteins (<40 nm) allows oligonucleotide ligation and amplification
Detect amplification products as fluorescent spots
Quantify and localize interaction events at subcellular resolution
FRET-based approaches with antibody validation:
Create fluorescent protein fusions to GER2 and potential interactors
Measure Förster Resonance Energy Transfer between fluorophores
Use GER2 Antibody to confirm appropriate expression of fusion proteins
Validate FRET results with co-IP experiments using the antibody
Bimolecular Fluorescence Complementation (BiFC):
Split fluorescent protein between GER2 and candidate interactor
Reconstitution of fluorescence indicates close proximity
Verify expression of fusion proteins using GER2 Antibody
Quantify interaction strength through fluorescence intensity
These advanced experimental designs leverage GER2 Antibody's specificity while combining it with other technologies to generate comprehensive datasets on GER2's protein interaction network, providing insights into its functional roles in plant biology.
Emerging technologies have the potential to significantly expand the utility of GER2 Antibody in plant research contexts:
Antibody engineering enhancements:
Generation of recombinant single-chain variable fragments (scFvs) based on GER2 Antibody
Development of nanobodies (VHH antibodies) against GER2 for improved tissue penetration
Creation of bispecific antibodies targeting GER2 and interacting proteins simultaneously
Engineering antibody fragments with reduced size for improved accessibility in plant tissues
Advanced imaging applications:
Super-resolution microscopy techniques (STORM, PALM) using directly labeled GER2 Antibody
Expansion microscopy protocols adapted for plant tissues with GER2 Antibody
Correlative light and electron microscopy (CLEM) integrating GER2 immunolocalization
Intravital imaging using membrane-permeable antibody derivatives
Multiplexed detection systems:
Mass cytometry (CyTOF) adapted for plant cell analysis with metal-tagged GER2 Antibody
Multiplexed ion beam imaging (MIBI) for simultaneous detection of multiple proteins
Sequential immunofluorescence with cyclic antibody stripping and reprobing
Antibody barcoding for simultaneous detection of multiple protein modifications
Functional modulation approaches:
Targeted protein degradation using GER2 Antibody conjugated to degradation-inducing moieties
Protein activity modulation through antibody-based proximity induction systems
Optogenetic control of protein function using antibody-photosensitive domain fusions
Single-cell applications:
Adaptation of CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing) for plant protoplasts
Development of plant-specific single-cell proteomics with GER2 Antibody detection
Integration with single-cell transcriptomics to correlate protein and mRNA levels
These emerging technologies represent the frontier of antibody applications in plant research, potentially transforming GER2 Antibody from a simple detection reagent into a versatile tool for multidimensional analysis and functional manipulation of GER2 protein in complex biological contexts.